Spots Global Cancer Trial Database for salivary gland cancer

Every month we try and update this database with for salivary gland cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer	NCT02048254	Salivary Gland ...	brachytherapy IMRT	18 Years - 80 Years	Peking University
Cabozantinib in Advanced Salivary Gland Cancer Patients	NCT03729297	Salivary Gland ...	Cabozantinib	18 Years -	Radboud University Medical Center
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors	NCT03517488	Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce...	XmAb20717	18 Years -	Xencor, Inc.
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC	NCT04140526	Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc...	ONC-392 Pembrolizumab Docetaxel	18 Years -	OncoC4, Inc.
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)	NCT04249947	Prostatic Neopl... Neoplasms by Hi... Neoplasms, Pros... Prostate Cancer Metastatic Cast... Neoplasms Prostatic Neopl... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Prostatic Disea... Salivary Gland ... Salivary Gland ... Adenoid Cystic ... Salivary Duct C... Mucoepidermoid ... Acinic Cell Tum...	P-PSMA-101 CAR-... Rimiducid	18 Years -	Poseida Therapeutics, Inc.
Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study	NCT05946577	Head Cancer Neck Cancer		18 Years -	Assistance Publique - Hôpitaux de Paris
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer	NCT00623129	Head and Neck C... Radiation Toxic... Xerostomia	questionnaire a... electroacupunct... management of t... quality-of-life...	21 Years - 89 Years	Mayo Clinic
Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study	NCT05008237	Salivary Gland ...	docetaxel plus ...	20 Years -	Samsung Medical Center
Cabozantinib in Advanced Salivary Gland Cancer Patients	NCT03729297	Salivary Gland ...	Cabozantinib	18 Years -	Radboud University Medical Center
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer	NCT00003489	Head and Neck C...	Antineoplaston ...	16 Years - 99 Years	Burzynski Research Institute
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients	NCT03924466	Metastatic Brea... Locally Advance... Cancer of Pancr... Solid Tumor Wit... Salivary Gland ... Gastric Cancer Endometrial Can... Uterine Cancer Non Small Cell ... Biliary Tract C... Cholangiocarcin... Colorectal Canc... Urothelial Carc... Prostate Cancer	68GaNOTA-Anti-H...	18 Years -	Universitair Ziekenhuis Brussel
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients	NCT03924466	Metastatic Brea... Locally Advance... Cancer of Pancr... Solid Tumor Wit... Salivary Gland ... Gastric Cancer Endometrial Can... Uterine Cancer Non Small Cell ... Biliary Tract C... Cholangiocarcin... Colorectal Canc... Urothelial Carc... Prostate Cancer	68GaNOTA-Anti-H...	18 Years -	Universitair Ziekenhuis Brussel
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	NCT03602079	HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin...	A166	18 Years -	Klus Pharma Inc.
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer	NCT02042885	Prostate Cancer Salivary Gland ... Endometrial Can... Squamous Cell C... Breast Cancer Ovarian Cancer	OPB-111001	18 Years -	Otsuka Novel Products GmbH
Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure	NCT00530049	Head and Neck C... Psychosocial Ef...	questionnaire a... assessment of t... psychosocial as... quality-of-life...	18 Years -	Memorial Sloan Kettering Cancer Center
Amivantamab in Adenoid Cystic Carcinoma	NCT05074940	Salivary Gland ...	Amivantamab	18 Years -	University of Cincinnati
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers	NCT00900419	Esophageal Canc... Head and Neck C... Lung Cancer Precancerous Co...	immunohistochem... laboratory biom... sputum cytology biopsy	21 Years - 90 Years	University of Colorado, Denver
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy	NCT01156142	Head and Neck C... Mucositis Oral Complicati... Pain	doxepin hydroch... placebo	18 Years -	Alliance for Clinical Trials in Oncology
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer	NCT00656513	Head and Neck C... Xerostomia	Pilocarpine ALTENS	18 Years -	Radiation Therapy Oncology Group
9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma	NCT04832438	Salivary Gland ... Adenoid Cystic ... Salivary Gland ... Salivary Gland ...	9-ING-41 Carboplatin	18 Years -	Actuate Therapeutics Inc.
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer	NCT00003489	Head and Neck C...	Antineoplaston ...	16 Years - 99 Years	Burzynski Research Institute
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors	NCT03360890	Thyroid Cancer Salivary Gland ...	Pembrolizumab Docetaxel	18 Years -	University of Chicago
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients	NCT02253238	Head and Neck C...	Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit...	18 Years -	M.D. Anderson Cancer Center
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas	NCT04620187	Salivary Gland ... HER2 Gene Mutat...	Ado-trastuzumab... Standard of Car... Standard of Car...	18 Years -	Dana-Farber Cancer Institute
Stereotactic Body Radiotherapy for Head and Neck Tumors	NCT01344356	Squamous Cell C... Nasopharyngeal ... Salivary Gland ... Head and Neck S... Paraganglioma o... Chordoma of Hea... Chondrosarcoma ... Angiofibroma of...	stereotactic bo... Stereotactic bo...	18 Years -	Mercy Research
APG-115 in Salivary Gland Cancer Trial	NCT03781986	Malignant Saliv... Salivary Gland ...	APG-115 Carboplatin	18 Years -	University of Michigan Rogel Cancer Center
Iressa Study in Patients With Salivary Gland Cancer	NCT00509002	Salivary Gland ...	Gefitinib	-	M.D. Anderson Cancer Center
Cell-free Tumor DNA in Head and Neck Cancer Patients	NCT03942380	Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl...	Liquid biopsy	18 Years -	Rigshospitalet, Denmark
Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer	NCT02048254	Salivary Gland ...	brachytherapy IMRT	18 Years - 80 Years	Peking University
Amivantamab in Adenoid Cystic Carcinoma	NCT05074940	Salivary Gland ...	Amivantamab	18 Years -	University of Cincinnati
Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC	NCT05898373	Salivary Gland ...	vedicitumomab (... vedicitumomab i... RC48 in combina... RC48 in combina...	18 Years -	Peking Union Medical College
APG-115 in Salivary Gland Cancer Trial	NCT03781986	Malignant Saliv... Salivary Gland ...	APG-115 Carboplatin	18 Years -	University of Michigan Rogel Cancer Center
Survival With Patients Treated With Salivary Gland Cancer	NCT05390294	Salivary Gland ... Salivary Gland ...	Surgical interv...	-	Clinical Center of Vojvodina
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors	NCT02576431	Solid Tumors Ha...	BAY2757556 (Lar...	18 Years -	Bayer
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia	NCT00052611	Head and Neck C...	Celecoxib	18 Years -	Dana-Farber Cancer Institute
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands	NCT00886132	Adenoid Cystic ... Salivary Gland ...	Sunitinib	18 Years -	University Health Network, Toronto
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas	NCT04620187	Salivary Gland ... HER2 Gene Mutat...	Ado-trastuzumab... Standard of Car... Standard of Car...	18 Years -	Dana-Farber Cancer Institute
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC	NCT04140526	Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc...	ONC-392 Pembrolizumab Docetaxel	18 Years -	OncoC4, Inc.
Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers	NCT06091878	Salivary Gland ...	Observation	18 Years -	Royal Marsden NHS Foundation Trust
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors	NCT03360890	Thyroid Cancer Salivary Gland ...	Pembrolizumab Docetaxel	18 Years -	University of Chicago
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients	NCT04291300	Salivary Gland ... Salivary Duct C... Adenoid Cystic ...	Lutetium-177-PS...	18 Years -	Radboud University Medical Center
Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure	NCT00530049	Head and Neck C... Psychosocial Ef...	questionnaire a... assessment of t... psychosocial as... quality-of-life...	18 Years -	Memorial Sloan Kettering Cancer Center
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers	NCT04209660	Adenoid Cystic ... Salivary Gland ...	Lenvatinib Pembrolizumab	18 Years -	Memorial Sloan Kettering Cancer Center
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors	NCT05941507	Advanced Solid ...	LCB84 Anti-PD-1 monoc...	18 Years -	LigaChem Biosciences, Inc.
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer	NCT01969578	Salivary Gland ...	bicalutamide + ... Cisplatin + Dox... Carboplatin + P...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer	NCT00656513	Head and Neck C... Xerostomia	Pilocarpine ALTENS	18 Years -	Radiation Therapy Oncology Group
Amivantamab in Adenoid Cystic Carcinoma	NCT05074940	Salivary Gland ...	Amivantamab	18 Years -	University of Cincinnati
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients	NCT02253238	Head and Neck C...	Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit...	18 Years -	M.D. Anderson Cancer Center
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy	NCT01156142	Head and Neck C... Mucositis Oral Complicati... Pain	doxepin hydroch... placebo	18 Years -	Alliance for Clinical Trials in Oncology
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer	NCT00623129	Head and Neck C... Radiation Toxic... Xerostomia	questionnaire a... electroacupunct... management of t... quality-of-life...	21 Years - 89 Years	Mayo Clinic
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma	NCT05010629	Salivary Gland ... Recurrent Saliv... Metastatic Canc... Adenoid Cystic ...	9-ING-41 Carboplatin	18 Years -	Dana-Farber Cancer Institute
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients	NCT02253238	Head and Neck C...	Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit...	18 Years -	M.D. Anderson Cancer Center
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer	NCT03172624	Salivary Gland ...	Nivolumab Ipilimumab	18 Years -	Memorial Sloan Kettering Cancer Center
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes	NCT02069730	Salivary Gland ... Metastatic Advanced Recurrent	Selinexor EGFR or HER2 In... FGFR Inhibitor C-KIT Inhibitor Anti-androgen NOTCH Inhibitor MEK or PI3K Inh...	18 Years -	University Health Network, Toronto
Cell-free Tumor DNA in Head and Neck Cancer Patients	NCT03942380	Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl...	Liquid biopsy	18 Years -	Rigshospitalet, Denmark
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma	NCT05010629	Salivary Gland ... Recurrent Saliv... Metastatic Canc... Adenoid Cystic ...	9-ING-41 Carboplatin	18 Years -	Dana-Farber Cancer Institute
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer	NCT03172624	Salivary Gland ...	Nivolumab Ipilimumab	18 Years -	Memorial Sloan Kettering Cancer Center
Integrated Cancer Repository for Cancer Research	NCT02012699	Pancreatic Canc... Thyroid Cancer Lung Cancer Esophageal Canc... Thymus Cancer Colon Cancer Rectal Cancer Gastrointestina... Anal Cancer Bile Duct Cance... Duodenal Cancer Gallbladder Can... Gastric Cancer Liver Cancer Small Intestine... Peritoneal Surf... Familial Adenom... Lynch Syndrome Bladder Cancer Kidney Cancer Penile Cancer Prostate Cancer Testicular Canc... Ureter Cancer Urethral Cancer Hypopharyngeal ... Laryngeal Cance... Lip Cancer Oral Cavity Can... Nasopharyngeal ... Oropharyngeal C... Paranasal Sinus... Nasal Cavity Ca... Salivary Gland ... Skin Cancer Central Nervous... Central Nervous... Mesothelioma Breast Cancer Leukemia Melanoma Sarcoma Unknown Primary... Multiple Myelom... Ovarian Cancer Endometrial Can... Vaginal Cancer Neuroendocrine ... Plasma Cell Dys... Healthy Control		19 Years - 110 Years	University of Nebraska
9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma	NCT04832438	Salivary Gland ... Adenoid Cystic ... Salivary Gland ... Salivary Gland ...	9-ING-41 Carboplatin	18 Years -	Actuate Therapeutics Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: